Arthrocare (ARTC -17.8%) shares plunges a day after reporting a substantial Q4 loss attributed...


Arthrocare (ARTC -17.8%) shares plunges a day after reporting a substantial Q4 loss attributed largely to hefty charges related to a proposed settlement of certain securities class action suits. Jefferies cuts its stock rating to Hold from Buy and drops its price target to $25 from $32, citing the "new and entirely unexpected" investigation which will preclude an anticipated takeover.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs